GB0614620D0 - Assay for diagnosing a predisposition to pathological bone conditions and anticipating response to treatment - Google Patents
Assay for diagnosing a predisposition to pathological bone conditions and anticipating response to treatmentInfo
- Publication number
- GB0614620D0 GB0614620D0 GB0614620A GB0614620A GB0614620D0 GB 0614620 D0 GB0614620 D0 GB 0614620D0 GB 0614620 A GB0614620 A GB 0614620A GB 0614620 A GB0614620 A GB 0614620A GB 0614620 D0 GB0614620 D0 GB 0614620D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- response
- treatment
- anticipating
- predisposition
- diagnosing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Methods and kits are provided for detection of specific polymorphisms that predispose towards osteoporosis and/or are indicative of likely response to treatment. Particular genes analysed are i) calcitonin Receptor; Vitamin D Receptor; Estrogen Receptor; Collagen I A1; and/or ii) Osteoprotegerin, LRP5, CYP17, CYP19 and MTHFR genes. The two groups may be analysed in separate multiplex amplification reactions on a sample.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0614620A GB0614620D0 (en) | 2006-07-24 | 2006-07-24 | Assay for diagnosing a predisposition to pathological bone conditions and anticipating response to treatment |
EP07789345A EP2046987A2 (en) | 2006-07-24 | 2007-07-23 | Assay for diagnosing a predisposition to pathological bone conditions and anticipating response to treatment |
PCT/GB2007/050434 WO2008012576A2 (en) | 2006-07-24 | 2007-07-23 | Assay for diagnosing a predisposition to pathological bone conditions and anticipating response to treatment |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0614620A GB0614620D0 (en) | 2006-07-24 | 2006-07-24 | Assay for diagnosing a predisposition to pathological bone conditions and anticipating response to treatment |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0614620D0 true GB0614620D0 (en) | 2006-08-30 |
Family
ID=36998578
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0614620A Ceased GB0614620D0 (en) | 2006-07-24 | 2006-07-24 | Assay for diagnosing a predisposition to pathological bone conditions and anticipating response to treatment |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP2046987A2 (en) |
GB (1) | GB0614620D0 (en) |
WO (1) | WO2008012576A2 (en) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1054066B1 (en) * | 1999-05-18 | 2007-10-17 | Nipro Corporation | Method for anticipating sensitivity to medicine for osteoporosis and a reagent therefor |
DE10201463B4 (en) * | 2002-01-16 | 2005-07-21 | Clondiag Chip Technologies Gmbh | Reaction vessel for performing array method |
-
2006
- 2006-07-24 GB GB0614620A patent/GB0614620D0/en not_active Ceased
-
2007
- 2007-07-23 WO PCT/GB2007/050434 patent/WO2008012576A2/en active Application Filing
- 2007-07-23 EP EP07789345A patent/EP2046987A2/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
WO2008012576A3 (en) | 2008-05-29 |
WO2008012576A2 (en) | 2008-01-31 |
EP2046987A2 (en) | 2009-04-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Hong et al. | DNA methylation-based age prediction from saliva: High age predictability by combination of 7 CpG markers | |
WO2007146819A3 (en) | Methods for identifying and using snp panels | |
NO20083461L (en) | Gene expression markers for colorectal cancer prognosis | |
EP2118298A4 (en) | Nucleic acid-based tests for rhd typing, gender determination and nucleic acid quantification | |
WO2007114947A3 (en) | Highly sensitive system and methods for analysis of troponin | |
WO2007095644A3 (en) | Reagents and methods for cancer prognosis and pathological staging | |
WO2011063274A3 (en) | Methods to predict clinical outcome of cancer | |
JP2011520451A (en) | Diagnosis of melanoma and Nikko Kuroko by nucleic acid analysis | |
WO2007100919A3 (en) | Markers for addiction | |
WO2008136996A3 (en) | Polymorphisms in genes affecting ace-related disorders and uses thereof | |
WO2007064776A3 (en) | Markers for breast cancer | |
MX2010005060A (en) | Dna microarray based identification and mapping of balanced translocation breakpoints. | |
WO2010051314A3 (en) | Genomic classification of non-small cell lung carcinoma based on patterns of gene copy number alterations | |
WO2009021054A3 (en) | Novel single nucleotide polymorphisms and combinations of novel and known polymorphisms for determining the allele-specific expression of the igf2 gene | |
BRPI0811930B8 (en) | methods and diagnostic or prognostic kit for lupus in an individual | |
IL182519A0 (en) | Methods and compositions for predicting drug responses | |
MXPA06014175A (en) | Diagnosing or predicting the course of breast cancer. | |
WO2013132074A3 (en) | A genotyping test for assessing risk of autism | |
WO2008058238A3 (en) | Adenosine a1 and a3 receptor gene sequence variations for predicting disease outcome and treatment outcome | |
WO2007140599A8 (en) | Assessment of risk for colorectal cancer | |
MX2010002993A (en) | Use of clec1b for the determination of cardiovascular and thrombotic risk. | |
GB0614620D0 (en) | Assay for diagnosing a predisposition to pathological bone conditions and anticipating response to treatment | |
WO2005083128A3 (en) | Methods for predicting cancer outcome and gene signatures for use therein | |
WO2008061527A3 (en) | Prognostic markers for classifying colorectal carcinoma on the basis of expression profiles of biological samples | |
GB2450454A (en) | Terminating substrates for DNA polymerases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |